GITTO, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.602
EU - Europa 2.267
AS - Asia 1.064
SA - Sud America 151
AF - Africa 25
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.587
RU - Federazione Russa 976
HK - Hong Kong 429
IT - Italia 363
PL - Polonia 330
IE - Irlanda 277
SG - Singapore 255
CN - Cina 181
BR - Brasile 139
SE - Svezia 111
IN - India 68
JO - Giordania 57
FI - Finlandia 47
DE - Germania 39
FR - Francia 36
ID - Indonesia 33
GB - Regno Unito 27
AU - Australia 25
VN - Vietnam 16
NL - Olanda 15
CA - Canada 12
CH - Svizzera 12
CI - Costa d'Avorio 12
RO - Romania 9
UA - Ucraina 8
ES - Italia 6
BD - Bangladesh 4
PT - Portogallo 4
ZA - Sudafrica 4
AR - Argentina 3
HU - Ungheria 3
IQ - Iraq 3
MA - Marocco 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
IL - Israele 2
KR - Corea 2
PY - Paraguay 2
AM - Armenia 1
BO - Bolivia 1
BS - Bahamas 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EU - Europa 1
JP - Giappone 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MX - Messico 1
NA - Namibia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
SA - Arabia Saudita 1
TG - Togo 1
TZ - Tanzania 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 7.135
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.429
Hong Kong 356
Fairfield 355
Warsaw 327
Dublin 277
Singapore 187
Ashburn 163
Woodbridge 142
Lawrence 134
Seattle 130
Altamura 112
Cambridge 112
Houston 105
Chandler 82
Wilmington 81
Princeton 67
Boston 66
Florence 65
Moscow 61
Mumbai 52
Ann Arbor 43
Beijing 40
San Diego 38
Jakarta 33
Helsinki 28
Shanghai 26
Melbourne 24
Hefei 22
Milan 21
New York 19
Medford 16
Dong Ket 14
Norwalk 14
Bengaluru 13
Boardman 13
Buffalo 13
Los Angeles 13
Abidjan 12
Lappeenranta 12
London 12
Rome 12
Bern 11
Bologna 11
Munich 10
West Jordan 10
Yubileyny 10
Falls Church 9
Frankfurt am Main 9
Hillsboro 9
Timisoara 9
Kent 8
Paris 8
Siena 7
Toronto 7
Barcelona 6
Turku 6
Belo Horizonte 5
Guangzhou 5
Padova 5
Phoenix 5
Prato 5
São Paulo 5
Chicago 4
Lisbon 4
Modena 4
Naples 4
Osimo 4
Parma 4
Prescot 4
Scandicci 4
The Dalles 4
Bexley 3
Carapicuíba 3
Garanhuns 3
Jacksonville 3
Laurel 3
Menlo Park 3
Minerbio 3
Nanjing 3
Palermo 3
Pisa 3
Porto Alegre 3
San Francisco 3
St Petersburg 3
Stockholm 3
Treviso 3
Villaricca 3
Alleghe 2
Amman 2
Ankara 2
Aosta 2
Asunción 2
Atlanta 2
Casablanca 2
Caserta 2
Castelliri 2
Cesena 2
Chennai 2
Council Bluffs 2
Curitiba 2
Totale 5.011
Salva come PNG Salva come JPEG
Nome #
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 235
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 217
Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients 162
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 141
Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods 136
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 130
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 125
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 120
Alcohol use disorder and liver transplant: new perspectives and critical issues 117
Super-resolution microscopy reveals an altered fibrin network in cirrhosis: The key role of oxidative stress in fibrinogen structural modifications 113
Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives 108
Hepatitis C virus recurrence after liver transplantation: A 10-year evaluation 104
Cellular and molecular mechanisms underlying liver fibrosis regression 104
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 102
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals. 100
Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study 99
Adherence to Mediterranean diet in liver transplant recipients: a cross-sectional multicenter study 98
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study 97
Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times 97
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) 96
Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study 95
Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing 93
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 93
Non-alcoholic fatty liver disease and metabolic syndrome after liver transplant 90
Gold standard assays for the monitoring of patients with chronic hepatitis C 90
Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients 90
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B. 85
Treatment of nonalcoholic steatohepatitis in adults: Present and future 85
Pattern of macrovascular invasion in hepatocellular carcinoma 85
Bioelectrical impedance vector analysis and cardiovascular performance in liver-transplanted recipients 84
Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients? 83
The changing scenario of hepatocellular carcinoma in Italy: an update 83
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status 82
Needs evaluation questionnaire for liver disease: a novel assessment of unmet needs in patients with chronic liver disease 80
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients 78
Biological therapies in patients with liver disease: are they really lifesavers? 78
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18 77
Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems 77
Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer 76
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 75
Metabolic Disorders After Liver Transplantation 73
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 72
Unsupervised Exercise Intervention vs. Adherence to a Mediterranean Diet Alone: The Role of Bioelectrical Impedance Vector Analysis and Cardiovascular Performance in Liver-Transplanted Recipients 71
Alcohol and viral hepatitis: A mini-review 71
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner? 71
Oxidative stress–induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular risk 69
Liver transplantation from hepatitis B surface antigen positive donors: A safe way to expand the donor pool 69
Statin-induced, immune-mediated injury with simultaneous targeting of skeletal muscle, skin and liver 68
Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: Sequence analysis and therapeutic strategy 67
Stem cells for end stage liver disease: How far have we got? 67
La prospettiva psicosomatica nella clinica dei trapianti d'organo. 65
A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy 64
Surgical site infection prevention and management in immunocompromised patients: a systematic review of the literature 63
Menopause, and not age, is a critical factor associated with a worse response to antiviral therapy in women affected by chronic hepatitis C 63
Familial intrahepatic cholestasis: New and wide perspectives 62
Impact of psychosocial status on liver transplant process 62
Study of the serum metabolomic profile in nonalcoholic fatty liver disease: Research and clinical perspectives 61
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 60
Liver transplantation for patients with alcoholic liver disease: An open question 60
Peginterferon-A-2B plus ribavirin is more effective than peginterferon-A-2A plus ribavirin in menopausal women with chronic hepatitis C 60
Reproductive Status Is Associated with the Severity of Fibrosis in Women with Hepatitis C 60
Non-alcoholic steatohepatitis and liver transplantation 59
The MELD score in patients awaiting liver transplant: Strengths and weaknesses 59
Impact of hepatitis C virus infection on health-related quality of life before and after liver transplantation: a multidisciplinary point of view 59
Worsening of serum lipid profile after direct acting antiviral treatment 58
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: A single center case-control study 57
Hepatitis C Virus-related chronic liver disease in elderly patients: An Italian cross-sectional study 57
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 57
Acute abdomen in the immunocompromised patient: WSES, SIS-E, WSIS, AAST, and GAIS guidelines 56
Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients 56
NS5A inhibitors for the treatment of hepatitis C infection 56
The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives 55
The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease 54
Letter: TNFα inhibitors and prevalence of fatty liver disease in chronic inflammatory diseases 54
Multidisciplinary view of alcohol use disorder: From a psychiatric illness to a major liver disease 53
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease article 53
Hepatitis B virus-related cryogobulinemic vasculitis. The role of antiviral nucleot(s)ide analogues: a review 53
Influence of age and gender before and after liver transplantation 52
Virological Treatment Monitoring for Chronic Hepatitis B 51
Vitamins in the treatment of chronic viral hepatitis 51
From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic 50
Microbiota and viral hepatitis: State of the art of a complex matter 50
In response 49
Physical activity in liver transplant recipients: a large multicenter study 48
Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog-treated patients 47
Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation 44
Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation 41
Hepatitis C: clinical management and debated issues 40
Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC 39
Primary biliary cholangitis associated with SARS-CoV-2 infection 38
Real-world analysis on the use of gamma-hydroxybutyric acid for alcohol withdrawal syndrome in hospitalized patients with diagnosis of cirrhosis 37
Metabolic Disorders in Liver Transplant Recipients: The State of the Art 35
Probiotics and the gut-liver axis 32
Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the Liver 20
HBV and HCV testing outcomes among marginalized communities in Italy, 2019–2024: a prospective study 19
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial 19
Relevance of Spontaneous Portosystemic Shunts Detected with CT in Patients with Cirrhosis 16
Frailty after Liver Transplantation: A Complex Unexplored Issue 15
Liver transplantation and nonalcoholic steatohepatitis: the state of the art 13
End-procedural adherence to recommended hemodynamic targets does not improve the outcome of elective tips in cirrhotic patients 10
Totale 7.270
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.431
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 0 0 0 0 0 0 0 0 0 34
2020/2021758 106 44 112 54 29 30 27 76 44 173 40 23
2021/2022445 4 28 58 9 13 5 14 38 40 30 60 146
2022/20231.013 102 287 35 37 25 189 143 48 91 9 30 17
2023/2024515 12 32 89 20 29 53 16 128 15 62 38 21
2024/20253.947 155 398 202 502 1.129 611 187 135 204 100 149 175
Totale 7.289